Search by Drug Name or NDC
NDC 00228-2849-03 Fluvoxamine Maleate 150 mg/1 Details
Fluvoxamine Maleate 150 mg/1
Fluvoxamine Maleate is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is FLUVOXAMINE MALEATE.
MedlinePlus Drug Summary
Fluvoxamine is used to treat obsessive-compulsive disorder (bothersome thoughts that won't go away and the need to perform certain actions over and over) and social anxiety disorder (extreme fear of interacting with others or performing in front of others that interferes with normal life). Fluvoxamine is in a class of medications called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Related Packages: 00228-2849-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fluvoxamine
Product Information
| NDC | 00228-2849 |
|---|---|
| Product ID | 0228-2849_31345079-f1be-48c5-adc6-5b79b4c6542f |
| Associated GPIs | 58160045107030 |
| GCN Sequence Number | 063768 |
| GCN Sequence Number Description | fluvoxamine maleate CAP ER 24H 150 MG ORAL |
| HIC3 | H2S |
| HIC3 Description | SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS) |
| GCN | 99482 |
| HICL Sequence Number | 006338 |
| HICL Sequence Number Description | FLUVOXAMINE MALEATE |
| Brand/Generic | Generic |
| Proprietary Name | Fluvoxamine Maleate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fluvoxamine Maleate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | FLUVOXAMINE MALEATE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091482 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00228-2849-03 (00228284903)
| NDC Package Code | 0228-2849-03 |
|---|---|
| Billing NDC | 00228284903 |
| Package | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2849-03) |
| Marketing Start Date | 2014-08-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 5.82056 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | FLUVOXAMINE ER 150 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis